Novel therapies for relapsed/refractory multiple myeloma: how can we improve on "salvage" therapy?--introduction
Semin Hematol
.
2012 Jul:49 Suppl 1:S1-2.
doi: 10.1053/j.seminhematol.2012.05.002.
Author
Andrzej Jakubowiak
1
Affiliation
1
University of Chicago Medical Center, Chicago, IL, USA.
PMID:
22727388
DOI:
10.1053/j.seminhematol.2012.05.002
No abstract available
Publication types
Introductory Journal Article
MeSH terms
Humans
Multiple Myeloma / drug therapy*
Recurrence
Salvage Therapy / methods*